{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T18:53:06Z","timestamp":1794077586498,"version":"4.8.0"},"reference-count":176,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005160","name":"American Society of Transplantation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ajt.2025.12.286","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:26:09Z","timestamp":1767918369000},"page":"1048-1069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Sensitization in organ transplantation: Assessment of Risk (STAR) 2025 meeting group report"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3274-3277","authenticated-orcid":false,"given":"Carrie A.","family":"Schinstock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-2752","authenticated-orcid":false,"given":"Howard","family":"Gebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5535-352X","authenticated-orcid":false,"given":"Idoia","family":"Gimferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-9822","authenticated-orcid":false,"given":"Marlena","family":"Habal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6700-188X","authenticated-orcid":false,"given":"Sebastiaan","family":"Heidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2648-2944","authenticated-orcid":false,"given":"Annette M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7298-1387","authenticated-orcid":false,"given":"Vasilis","family":"Kosmoliaptsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-3680","authenticated-orcid":false,"given":"Roslyn B.","family":"Mannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7307-923X","authenticated-orcid":false,"given":"Maria","family":"Meneghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-3356","authenticated-orcid":false,"given":"Michael","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6879-6370","authenticated-orcid":false,"given":"Anna","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5625-0792","authenticated-orcid":false,"given":"Maarten","family":"Naesens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-545X","authenticated-orcid":false,"given":"Elaine","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6196-4669","authenticated-orcid":false,"given":"Aleksandar","family":"Senev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-8963","authenticated-orcid":false,"given":"Olivier","family":"Thaunat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-5382","authenticated-orcid":false,"given":"Nicole","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-3545","authenticated-orcid":false,"given":"Chris","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0320-9825","authenticated-orcid":false,"given":"Anat R.","family":"Tambur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ajt.2025.12.286_bib1","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib2","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1111\/ajt.15937","article-title":"Sensitization in transplantation: assessment of risk (STAR) 2019 Working Group Meeting Report","volume":"20","author":"Tambur","year":"2020","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ajt.2022.11.009","article-title":"Sensitization in transplantation: assessment of Risk 2022 Working Group Meeting Report","volume":"23","author":"Tambur","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2025.12.286_bib4","article-title":"European society of organ transplantation consensus statement on testing for non-invasive diagnosis of kidney allograft rejection","volume":"36","author":"Park","year":"2023","journal-title":"Transpl Int."},{"key":"10.1016\/j.ajt.2025.12.286_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.12445","article-title":"European society for organ transplantation (ESOT) consensus statement on the use of non-invasive biomarkers for cardiothoracic transplant rejection surveillance","volume":"37","author":"Nikolova","year":"2024","journal-title":"Transpl Int."},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ajt.2025.12.286_bib7","series-title":"ASTS Statement on Donor Derived Cell-Free DNA (dd-cfDNA)\u2014Updated October 2024","author":"Surgeons","year":"2024"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib8","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1097\/TP.0000000000004212","article-title":"Combining donor-derived cell-free DNA fraction and quantity to detect kidney transplant rejection using molecular diagnoses and histology as confirmation","volume":"106","author":"Halloran","year":"2022","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.ajt.2025.12.286_bib9","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1111\/ajt.15416","article-title":"Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study","volume":"19","author":"Oellerich","year":"2019","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41598-020-80845-6","article-title":"Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients","volume":"11","author":"Zhao","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.286_bib11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajt.16835","article-title":"Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients","volume":"22","author":"Levitsky","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2025.12.286_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1089830","article-title":"Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipients","volume":"14","author":"Kueng","year":"2023","journal-title":"Front Genet"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001411","article-title":"Assessment of dd-cfDNA levels in clinically stable lung allograft recipients beyond the Initial 2 y posttransplant","volume":"8","author":"Trindade","year":"2022","journal-title":"Transplant Direct"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1373\/jalm.2016.022731","article-title":"Biological variation of donor-derived cell-free DNA in renal transplant recipients: clinical implications","volume":"2","author":"Bromberg","year":"2017","journal-title":"J Appl Lab Med"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib15","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/ajt.15339","article-title":"Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study","volume":"19","author":"Khush","year":"2019","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib16","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/clinchem\/hvaa175","article-title":"Time-dependent apparent increase in dd-cfDNA percentage in clinically stable patients between one and five years following kidney transplantation","volume":"66","author":"Sch\u00fctz","year":"2020","journal-title":"Clin Chem"},{"issue":"241","key":"10.1016\/j.ajt.2025.12.286_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007803","article-title":"Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection","volume":"6","author":"De Vlaminck","year":"2014","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15479","article-title":"Clinical utility of donor-derived cell-free DNA in heart transplant recipients with multi-organ transplants","volume":"38","author":"Moeller","year":"2024","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14101","article-title":"Impact of body mass index and recipient age on baseline donor-derived cell free DNA (dd-cfDNA) in kidney transplant recipients","volume":"34","author":"Sureshkumar","year":"2020","journal-title":"Clin Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2025.12.286_bib20","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.2215\/CJN.03840322","article-title":"Longitudinal evaluation of donor-derived Cellfree DNA in pediatric kidney transplantation","volume":"17","author":"Dandamudi","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.286_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14264","article-title":"Relationship between donor fraction cell-free DNA and clinical rejection in heart transplantation","volume":"26","author":"Deshpande","year":"2022","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ajt.2025.12.286_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.13919","article-title":"Evaluation of a decentralized donor-derived cell-free DNA assay for kidney allograft rejection monitoring","volume":"37","author":"Loupy","year":"2024","journal-title":"Transpl Int."},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/tan.15518","article-title":"Multi-centre analytical performance verification of an IVD assay to quantify donor-derived cell-free DNA in solid organ transplant recipients","volume":"103","author":"Casas","year":"2024","journal-title":"HLA"},{"key":"10.1016\/j.ajt.2025.12.286_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10134","article-title":"Patient-reported outcomes as endpoints in clinical trials of kidney transplantation interventions","volume":"35","author":"Tong","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.ajt.2025.12.286_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1435578","article-title":"Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation","volume":"15","author":"Cao","year":"2024","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ajt.2025.12.286_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001237","article-title":"Absolute or relative quantification of donor-derived cell-free DNA in kidney transplant recipients: case series","volume":"7","author":"Osmanodja","year":"2021","journal-title":"Transplant Direct"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001145","article-title":"Extremely high cell-free DNA levels observed in renal allograft patient with SARS-CoV-2 infection","volume":"7","author":"Bunnapradist","year":"2021","journal-title":"Transplant Direct"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib28","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1681\/ASN.2021050645","article-title":"Using both the fraction and quantity of donor-derived cell-free DNA to detect kidney allograft rejection","volume":"32","author":"Bunnapradist","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.286_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ajt.2024.09.029","article-title":"Donor-derived posttransplant lymphoproliferative disease detection by donor-derived cell-free DNA","volume":"25","author":"Wungnema","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2025.12.286_bib30","article-title":"Quantification of cell-free DNA in red blood cell units in different whole blood processing methods","volume":"2016","author":"Shih","year":"2016","journal-title":"J Blood Transfus"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib31","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1111\/ajt.17039","article-title":"Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients","volume":"22","author":"Keller","year":"2022","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.286_bib32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study","volume":"101","author":"Bu","year":"2022","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.286_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001487","article-title":"Relative change in donor-derived cell-free DNA is superior to absolute values for diagnosis of acute lung allograft dysfunction","volume":"9","author":"Trindade","year":"2023","journal-title":"Transplant Direct"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14582","article-title":"Utilization of donor-derived cell-Free DNA in pediatric kidney transplant recipients: A single center study","volume":"28","author":"Ranch","year":"2024","journal-title":"Pediatr Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.286_bib35","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41591-024-03087-3","article-title":"Cell-free DNA for the detection of kidney allograft rejection","volume":"30","author":"Aubert","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ajt.2025.12.286_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1031894","article-title":"Donor-derived cell-free DNA as a diagnostic tool in transplantation","volume":"13","author":"Oellerich","year":"2022","journal-title":"Front Genet"},{"issue":"11","key":"10.1016\/j.ajt.2025.12.286_bib37","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1111\/ajt.17125","article-title":"Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunction","volume":"22","author":"Bazemore","year":"2022","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.286_bib38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.healun.2023.11.008","article-title":"Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection","volume":"43","author":"Keller","year":"2024","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2025.12.286_bib39","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001019","article-title":"Donor-derived cell-free DNA in infections in kidney transplant recipients: case series","volume":"6","author":"Goussous","year":"2020","journal-title":"Transplant Direct"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.286_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001149","article-title":"Donor-derived cell-free DNA kinetics post-kidney transplant biopsy","volume":"7","author":"Kyeso","year":"2021","journal-title":"Transplant Direct"},{"issue":"11","key":"10.1016\/j.ajt.2025.12.286_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108160","article-title":"Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA","volume":"26","author":"Pang","year":"2023","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib42","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/ajt.16894","article-title":"High levels of donor-derived cell-free DNA in a case of Graft-versus-host-disease following liver transplantation","volume":"22","author":"Lewis","year":"2022","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2025.12.286_bib43","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.286_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.34067\/KID.0000042021","article-title":"Dynamic response of donor-derived cell-free DNA following treatment of acute rejection in kidney allografts","volume":"2","author":"Wolf-Doty","year":"2021","journal-title":"Kidney360"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.286_bib45","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jalm\/jfab171","article-title":"Biological variation of donor-derived cell-free DNA in stable lung transplant recipients","volume":"7","author":"Keller","year":"2022","journal-title":"J Appl Lab Med"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajt.2025.08.036","article-title":"2025 Report of the Sensitization in Transplantation: assessment of Risk Working Group on donor-derived cell-free DNA: establishing analytical validity as the basis for appropriate and effective clinical utilization","volume":"26","author":"Valenzuela","year":"2026","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib47","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/CIRCULATIONAHA.116.022907","article-title":"Gene expression profiling for the identification and classification of antibody-mediated heart rejection","volume":"135","author":"Loupy","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib48","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41591-025-03653-3","article-title":"Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies","volume":"31","author":"Diebold","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.ajt.2025.12.286_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.13209","article-title":"Natural killer cell presence in antibody-mediated rejection","volume":"37","author":"Diebold","year":"2024","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib50","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.286_bib51","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1681\/ASN.2020111558","article-title":"Missing self-induced microvascular rejection of kidney allografts: A population-based study","volume":"32","author":"Callemeyn","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib52","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/TP.0000000000005228","article-title":"Functional natural killer-cell genetics and microvascular inflammation after kidney transplantation: an observational cohort study","volume":"109","author":"Diebold","year":"2025","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.286_bib53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1681\/ASN.2020040433","article-title":"Missing self-induced activation of NK cells combines with non-complement-fixing donor-specific antibodies to accelerate kidney transplant loss in chronic antibody-mediated rejection","volume":"32","author":"Koenig","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib54","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ajt.2023.12.005","article-title":"Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation","volume":"24","author":"Diebold","year":"2024","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/tan.14332","article-title":"Allograft recognition by recipient\u2019s natural killer cells: molecular mechanisms and role in transplant rejection","volume":"98","author":"Hamada","year":"2021","journal-title":"HLA"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib56","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00007890-198305000-00013","article-title":"Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts","volume":"35","author":"Hancock","year":"1983","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.ajt.2025.12.286_bib57","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/ajt.12803","article-title":"The role of macrophages in the development of human renal allograft fibrosis in the first year after transplantation","volume":"14","author":"Toki","year":"2014","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib58","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1681\/ASN.2014080804","article-title":"Dendritic cells in kidney transplant biopsy samples are associated with T cell infiltration and poor allograft survival","volume":"26","author":"Batal","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.286_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156900","article-title":"Infiltration of macrophages correlates with severity of allograft rejection and outcome in human kidney transplantation","volume":"11","author":"Bergler","year":"2016","journal-title":"PLOS One"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.286_bib60","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.kint.2017.01.029","article-title":"Macrophage density in early surveillance biopsies predicts future renal transplant function","volume":"92","author":"Br\u00e4sen","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib61","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1038\/s41467-023-39859-7","article-title":"Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection","volume":"14","author":"Lamarth\u00e9e","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib62","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/s41591-024-03030-6","article-title":"Decoding the hallmarks of allograft dysfunction with a comprehensive pan-organ transcriptomic atlas","volume":"30","author":"Robertson","year":"2024","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib63","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.4049\/jimmunol.0902194","article-title":"An innate response to allogeneic nonself mediated by monocytes","volume":"183","author":"Zecher","year":"2009","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aam6202","article-title":"Donor SIRPalpha polymorphism modulates the innate immune response to allogeneic grafts","volume":"2","author":"Dai","year":"2017","journal-title":"Sci Immunol"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.286_bib65","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1172\/JCI74370","article-title":"Non-self recognition by monocytes initiates allograft rejection","volume":"124","author":"Oberbarnscheidt","year":"2014","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.286_bib66","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.4049\/jimmunol.1102997","article-title":"Innate NK cells and macrophages recognize and reject allogeneic nonself in vivo via different mechanisms","volume":"188","author":"Liu","year":"2012","journal-title":"J Immunol"},{"issue":"807","key":"10.1016\/j.ajt.2025.12.286_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ady1135","article-title":"Donor-recipient mismatch at the SIRPA locus adversely affects kidney allograft outcomes","volume":"17","author":"Zhao","year":"2025","journal-title":"Sci Transl Med"},{"issue":"17","key":"10.1016\/j.ajt.2025.12.286_bib68","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/bloodadvances.2021004307","article-title":"Mismatch in SIRP\u03b1, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantation","volume":"5","author":"Saliba","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.humimm.2006.10.003","article-title":"HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP","volume":"68","author":"Duquesnoy","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ajt.2025.12.286_bib70","article-title":"A comprehensive evaluation of the antibody-verified status of eplets listed in the HLA epitope registry","volume":"12","author":"Bezstarosti","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib71","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.4049\/jimmunol.1800683","article-title":"Predicting humoral alloimmunity from differences in donor and recipient HLA surface electrostatic potential","volume":"201","author":"Mallon","year":"2018","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.286_bib72","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.immuni.2025.01.008","article-title":"Identification of indirect CD4+ T cell epitopes associated with transplant rejection provides a target for donor-specific tolerance induction","volume":"58","author":"Zhanzak","year":"2025","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.ajt.2025.12.286_bib73","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/molbev\/msy116","article-title":"Divergent allele advantage at human MHC genes: signatures of past and ongoing selection","volume":"35","author":"Pierini","year":"2018","journal-title":"Mol Biol Evol"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib74","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1038\/s41467-025-60485-y","article-title":"Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allografts","volume":"16","author":"Demir","year":"2025","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib75","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.7326\/M20-7957","article-title":"Donor HLA Class 1 evolutionary divergence is a major predictor of liver allograft rejection: A retrospective cohort study","volume":"174","author":"F\u00e9ray","year":"2021","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ajt.2025.12.286_bib76","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41591-019-0639-4","article-title":"Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy","volume":"25","author":"Chowell","year":"2019","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib77","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/molbev\/msz249","article-title":"HLA heterozygote advantage against HIV-1 is driven by quantitative and qualitative differences in HLA allele-specific peptide presentation","volume":"37","author":"Arora","year":"2020","journal-title":"Mol Biol Evol"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.286_bib78","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/ajt.15177","article-title":"HLA-DR\/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity","volume":"19","author":"Wiebe","year":"2019","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2025.12.286_bib79","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2020010019","article-title":"Eplet mismatch load and de novo occurrence of donor-specific anti-HLA antibodies, Rejection, and graft failure after kidney transplantation: an observational cohort study","volume":"31","author":"Senev","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib80","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/tan.15008","article-title":"HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy","volume":"102","author":"Bezstarosti","year":"2023","journal-title":"HLA"},{"key":"10.1016\/j.ajt.2025.12.286_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101908","article-title":"Impact of HLA eplet mismatch load in immunological outcomes after living donor kidney transplantation","volume":"80","author":"Alves","year":"2023","journal-title":"Transpl Immunol"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.286_bib82","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1111\/ajt.16563","article-title":"Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: results of the CELLIMIN trial","volume":"21","author":"Bestard","year":"2021","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib83","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1111\/ajt.14951","article-title":"Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantation","volume":"18","author":"McCaughan","year":"2018","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.286_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/tan.15455","article-title":"Qualitative, rather than quantitative, differences between HLA-DQ alleles affect HLA-DQ immunogenicity in organ transplantation","volume":"103","author":"Maguire","year":"2024","journal-title":"HLA"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.286_bib85","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-Mediated Rejection Due to Preexisting versus de novo Donor-Specific antibodies in Kidney Allograft Recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.286_bib86","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/ajt.14161","article-title":"The value of protocol biopsies to identify patients with de novo donor-specific antibody at high risk for allograft loss","volume":"17","author":"Schinstock","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2025.12.286_bib87","article-title":"Living donor kidney transplantation in patients with donor-specific HLA antibodies after desensitization with immunoadsorption","volume":"8","author":"K\u00e4lble","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib88","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001139","article-title":"Marginal impact of tocilizumab monotherapy on anti-HLA alloantibodies in highly sensitized kidney transplant candidates","volume":"7","author":"Daligault","year":"2021","journal-title":"Transplant Direct"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib89","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.healun.2021.11.010","article-title":"Post-transplantation outcomes of sensitized patients receiving durable mechanical circulatory support","volume":"41","author":"Youn","year":"2022","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2025.12.286_bib90","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.ajt.2023.04.033","article-title":"Outcomes after flow cytometry crossmatch-positive lung transplants managed with perioperative desensitization","volume":"23","author":"Aversa","year":"2023","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.286_bib91","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/ajt.17060","article-title":"Heart transplantation across preformed donor-specific antibody barriers using a perioperative desensitization protocol","volume":"22","author":"Sommer","year":"2022","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib92","first-page":"1993","article-title":"Low incidence of acute antibody-mediated rejection after HLA desensitization in living donor kidney transplant recipients","volume":"12","author":"Fern\u00e1ndez Rivera","year":"2022","journal-title":"Life (Basel)"},{"issue":"9","key":"10.1016\/j.ajt.2025.12.286_bib93","article-title":"Efficacy of combined desensitization therapy based on protein A immunoadsorption on anti-human leukocyte antigen antibodies in sensitized kidney transplant recipients: A retrospective study","volume":"14","author":"Chen","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib94","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.htct.2022.11.009","article-title":"Role of therapeutic plasma exchange as a desensitization therapy in human leukocyte antigen incompatible renal transplant patients: a single-center experience","volume":"46","author":"Chowdhry","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.286_bib95","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14907","article-title":"Efficacy of bortezomib desensitization among heart transplant candidates","volume":"37","author":"Brinkley","year":"2023","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.286_bib96","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.transproceed.2023.01.006","article-title":"Desensitizing with temporary donor splenic transplant: hope for the sensitized patients on pancreas and kidney\u2014pancreas transplant waitlist","volume":"55","author":"Di Cocco","year":"2023","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.286_bib97","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ajt.2023.02.022","article-title":"Effects of invivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates","volume":"23","author":"Rossi","year":"2023","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.286_bib98","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.34067\/KID.0000000000000113","article-title":"Ixazomib for desensitization (IXADES) in highly sensitized kidney transplant candidates: a phase II clinical trial","volume":"4","author":"Wilson","year":"2023","journal-title":"Kidney360"},{"issue":"11","key":"10.1016\/j.ajt.2025.12.286_bib99","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ajt.2023.04.034","article-title":"Lung transplantation despite preformed donor-specific antihuman leukocyte antigen antibodies: a 9-year single-center experience","volume":"23","author":"Heise","year":"2023","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib100","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.healun.2023.05.001","article-title":"Three year post heart transplant outcomes of desensitized durable mechanical circulatory support patients","volume":"42","author":"Youn","year":"2023","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib101","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/jca.22053","article-title":"Modifications to therapeutic plasma exchange to achieve rapid exchange on cardiopulmonary bypass prior to pediatric cardiac transplant","volume":"38","author":"Davies","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.ajt.2025.12.286_bib102","article-title":"A modified perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy","volume":"14","author":"Guo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2025.12.286_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.10844","article-title":"Additional benefits of rituximab and plasma exchange on top of standard induction therapy in kidney transplant recipients with a negative CDC crossmatch but high preformed donor specific antibody titer","volume":"36","author":"Mohamadou","year":"2023","journal-title":"Transpl Int."},{"key":"10.1016\/j.ajt.2025.12.286_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101904","article-title":"Preemptive immune globulin therapy in sensitized lung transplant recipients","volume":"80","author":"Goldsby","year":"2023","journal-title":"Transpl Immunol"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib105","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.ajt.2023.08.006","article-title":"Impact of donor-specific anti-HLA antibody on cardiac hemodynamics and graft function 3 years after pediatric heart transplantation: first results from the CTOTC-09 multi-institutional study","volume":"23","author":"Webber","year":"2023","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib106","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1681\/ASN.0000000000000287","article-title":"Isatuximab monotherapy for desensitization in highly sensitized patients awaiting kidney transplant","volume":"35","author":"Vincenti","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajt.2025.12.286_bib107","article-title":"Pre-transplant crossmatch-negative donor-specific anti-HLA antibody predicts acute antibody-mediated rejection but not long-term outcomes in kidney transplantation: an analysis of the Korean Organ Transplantation Registry","volume":"15","author":"Lee","year":"2024","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ajt.2025.12.286_bib108","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15374","article-title":"Intravenous immunoglobulins alone for the desensitization of lung transplant recipients with preformed donor specific antibodies and negative flow cytometry crossmatch","volume":"38","author":"Abdulqawi","year":"2024","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib109","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15165","article-title":"Does bortezomib influence pre-transplant desensitization therapy or benefit post-heart transplant outcomes for highly sensitized patients?","volume":"38","author":"Dhillon","year":"2024","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ajt.2025.12.286_bib110","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.941346","article-title":"Living donor liver transplantation in patients with preformed donor-specific anti-human leukocyte antigen antibodies using preoperative desensitization therapy according to intensity of donor-specific antibodies: a single-center study","volume":"28","author":"Ogawa","year":"2023","journal-title":"Ann Transplant"},{"key":"10.1016\/j.ajt.2025.12.286_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11212","article-title":"Immunoadsorption-based HLA desensitization in patients awaiting deceased donor kidney transplantation: an interventional, non-randomised, single cohort study","volume":"36","author":"Bureau","year":"2023","journal-title":"Transpl Int."},{"issue":"7","key":"10.1016\/j.ajt.2025.12.286_bib112","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/ajt.16420","article-title":"Complement inhibition for prevention of antibody-mediated rejection in immunologically high-risk heart allograft recipients","volume":"21","author":"Patel","year":"2021","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2025.12.286_bib113","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1016\/j.ekir.2024.08.020","article-title":"Open-label Phase 1\/2 study of daratumumab-based desensitization before kidney transplantation","volume":"9","author":"Pilon","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib114","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1038\/s41598-023-34804-6","article-title":"Comparison of high-dose IVIG and rituximab versus rituximab as a preemptive therapy for de novo donor-specific antibodies in kidney transplant patients","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib115","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000528748","article-title":"Efficacy of double membrane filtration immunoadsorption in severe C1q-binding donor-specific antibody-positive acute humoral kidney allograft rejection: a case series","volume":"52","author":"Russwurm","year":"2023","journal-title":"Blood Purif"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib116","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/1744-9987.13937","article-title":"A comparison of methods of plasmapheresis for the treatment of late antibody mediated rejection in kidney transplant recipients","volume":"27","author":"Caliskan","year":"2023","journal-title":"Ther Apher Dial"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib117","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14454","article-title":"Eculizumab for antibody-mediated rejection in heart transplantation: A case-control study","volume":"35","author":"Kittleson","year":"2021","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib118","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14853","article-title":"Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients","volume":"37","author":"Khairallah","year":"2023","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ajt.2025.12.286_bib119","article-title":"Differential treatment effects for renal transplant recipients with DSA-positive or DSA-negative antibody-mediated rejection","volume":"9","author":"Koslik","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajt.2025.12.286_bib120","article-title":"Tocilizumab in the treatment of chronic antibody-mediated rejection post kidney transplantation: clinical and histological monitoring","volume":"8","author":"Noble","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajt.2025.12.286_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101703","article-title":"Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients","volume":"75","author":"Razia","year":"2022","journal-title":"Transpl Immunol"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib122","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14936","article-title":"Tocilizumab for treatment of chronic active antibody-mediated rejection in kidney transplant recipients","volume":"37","author":"Boonpheng","year":"2023","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.286_bib123","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ekir.2022.01.1074","article-title":"Evaluation of Clazakizumab (anti-interleukin-6) in patients with treatment-resistant chronic active antibody-mediated rejection of kidney allografts","volume":"7","author":"Jordan","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib124","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/LVT.0000000000000200","article-title":"Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study","volume":"29","author":"Dumortier","year":"2023","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ajt.2025.12.286_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101737","article-title":"Conversion to Belatacept in kidney transplant recipients with chronic antibody-mediated rejection (CAMR)","volume":"76","author":"Moein","year":"2023","journal-title":"Transpl Immunol"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.286_bib126","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14524","article-title":"Chronic intermittent intravenous immunoglobulin in heart transplant recipients with elevated donor-specific antibody levels","volume":"36","author":"Yopes","year":"2022","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.286_bib127","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ajt.2022.12.019","article-title":"Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death","volume":"23","author":"Keller","year":"2023","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.286_bib128","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14734","article-title":"Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients","volume":"36","author":"Pearl","year":"2022","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib129","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.healun.2023.05.012","article-title":"Tocilizumab for antibody-mediated rejection treatment in lung transplantation","volume":"42","author":"January","year":"2023","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.286_bib130","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.transproceed.2022.08.008","article-title":"Lack of efficacy and safety of eculizumab for treatment of antibody-mediated rejection following renal transplantation","volume":"54","author":"Heo","year":"2022","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.286_bib131","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized Phase 2 trial of felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ajt.2025.12.286_bib132","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15383","article-title":"A randomized trial comparing Imlifidase to plasmapheresis in kidney transplant recipients with antibody-mediated rejection","volume":"38","author":"Halleck","year":"2024","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ajt.2025.12.286_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.662441","article-title":"Efficacy and safety of bone marrow-derived mesenchymal stem cells for chronic antibody-mediated rejection after kidney transplantation- A single-arm, two-dosing-regimen, Phase I\/II study","volume":"12","author":"Wei","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.286_bib134","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/TP.0000000000004689","article-title":"Imlifidase desensitization in HLA-incompatible kidney transplantation: finding the sweet spot","volume":"108","author":"de Weerd","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2025.12.286_bib135","article-title":"Desensitization with Imlifidase for HLA-incompatible deceased donor kidney transplantation: A Delphi international expert consensus","volume":"37","author":"Furian","year":"2024","journal-title":"Transpl Int."},{"key":"10.1016\/j.ajt.2025.12.286_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11244","article-title":"Imlifidase for kidney transplantation of highly sensitized patients with a positive crossmatch: the French consensus guidelines","volume":"36","author":"Couzi","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.ajt.2025.12.286_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11616","article-title":"Prime time for HLA desensitization: Imlifidase in the spotlight","volume":"36","author":"Bestard","year":"2023","journal-title":"Transpl Int."},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2025.100919","article-title":"Spanish guidelines for kidney transplantation in highly sensitized patients with donor-specific anti-HLA antibodies","volume":"39","author":"Mancebo","year":"2025","journal-title":"Transplant Rev (Orlando)"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib139","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/ndt\/gfy088","article-title":"The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft loss","volume":"33","author":"Courant","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2025.12.286_bib140","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.transproceed.2022.10.011","article-title":"Non-HLA antibodies and their role in highly sensitized patients","volume":"54","author":"Roa-Bautista","year":"2022","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ajt.2025.12.286_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101670","article-title":"SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies","volume":"74","author":"Wijtvliet","year":"2022","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.ajt.2025.12.286_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10099","article-title":"Clinical significances of anti-collagen type I and Type III antibodies in antibody-mediated rejection","volume":"35","author":"Park","year":"2022","journal-title":"Transpl Int."},{"key":"10.1016\/j.ajt.2025.12.286_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.809059","article-title":"The pre-transplant non-HLA Antibody Burden Associates with the development of histology of antibody-mediated rejection after kidney transplantation","volume":"13","author":"Senev","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2025.12.286_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101674","article-title":"Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients","volume":"74","author":"Liu","year":"2022","journal-title":"Transpl Immunol"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib145","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1007\/s00467-023-06055-0","article-title":"Angiotensin II type 1 receptor antibodies and native kidney function in pediatric liver and intestinal transplant recipients","volume":"38","author":"Stern","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.ajt.2025.12.286_bib146","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3390\/jcm12093112","article-title":"The influence of antibodies against angiotensin II type-1 receptor on the outcome of kidney transplantation: a single-center retrospective study","volume":"12","author":"Filiopoulos","year":"2023","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.286_bib147","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14400","article-title":"Pre-transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: an observational cohort study","volume":"26","author":"Pizzo","year":"2022","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib148","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00005-022-00660-x","article-title":"Angiotensin II Type 1 receptor antibodies are higher in lupus nephritis and vasculitis than other glomerulonephritis patients","volume":"70","author":"Szymczak","year":"2022","journal-title":"Arch Immunol Ther Exp (Warsz)."},{"issue":"11","key":"10.1016\/j.ajt.2025.12.286_bib149","first-page":"698","article-title":"Relationship between angiotensin II Type 1 receptor antibody positivity and cytokine gene polymorphism in renal transplant patients when organ rejection occurs","volume":"23","author":"Yantir","year":"2022","journal-title":"Exp Clin Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib150","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/1389203722666210706163149","article-title":"Evaluation of antibodies directed against two GPCRs, anti-AT1R and anti-ETAR, on kidney transplant outcome","volume":"22","author":"El Band","year":"2021","journal-title":"Curr Protein Pept Sci"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib151","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13987","article-title":"Non-HLA AT1R antibodies are highly prevalent after pediatric intestinal transplantation","volume":"25","author":"Chan","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.12.286_bib152","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/TP.0000000000004753","article-title":"Non-HLA antibodies to G protein-coupled receptors in pediatric kidney transplant recipients: short- and long-term clinical outcomes","volume":"108","author":"Pearl","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2025.12.286_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101943","article-title":"Anti-GSTT1 antibodies and Null genotype correlate with histological changes of antibody mediated rejection in kidney transplantation","volume":"81","author":"Obri\u015fc\u0103","year":"2023","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.ajt.2025.12.286_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101794","article-title":"Pre-existing non-human leukocyte antigen antibodies are associated with allograft rejection after thoracic transplantation","volume":"77","author":"Yeo","year":"2023","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.ajt.2025.12.286_bib155","article-title":"Anti-glutathione S-transferase theta 1 antibodies correlate with graft loss in non-sensitized pediatric kidney recipients","volume":"9","author":"Comoli","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib156","doi-asserted-by":"crossref","first-page":"901","DOI":"10.6002\/ect.2022.0189","article-title":"Anti-glutathione S transferase T1 antibodies after renal transplant and their impact on graft outcome","volume":"20","author":"Valencia Pereira","year":"2022","journal-title":"Exp Clin Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2025.12.286_bib157","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001621","article-title":"Very low frequency of pathological findings in one-year protocol biopsies of uneventful standard risk kidney transplant recipients: results from the Nordic protocol biopsy study","volume":"10","author":"Helanter\u00e4","year":"2024","journal-title":"Transplant Direct"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib158","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.humimm.2023.07.006","article-title":"Study of association between antibodies to non-HLA kidney self-antigens and progression to chronic immune injury after kidney transplantation","volume":"84","author":"Nair","year":"2023","journal-title":"Hum Immunol"},{"issue":"6","key":"10.1016\/j.ajt.2025.12.286_bib159","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.3390\/jcm12062302","article-title":"Nailfold videocapillaroscopy for non-invasive assessment of microcirculation and prognostic correlation with endothelial dysfunction, cardiovascular risk factors, and non-HLA antibodies in heart transplant recipients: A pilot study","volume":"12","author":"Sikorska","year":"2023","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib160","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/jcm11030833","article-title":"Non-HLA antibodies in hand transplant recipients are connected to multiple acute rejection episodes and endothelial activation","volume":"11","author":"Sikorska","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajt.2025.12.286_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.703457","article-title":"Non-HLA antibodies and epitope mismatches in kidney transplant recipients with histological antibody-mediated rejection","volume":"12","author":"Crespo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajt.2025.12.286_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1289744","article-title":"Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-alpha signaling","volume":"14","author":"Moll","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ajt.2025.12.286_bib163","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/tan.14858","article-title":"Complement component C3 and C5b-9 deposition on hypoxia reperfused endothelial cells by non-HLA antibodies against RhoGDI2: A player involved in graft failure?","volume":"101","author":"Kardol-Hoefnagel","year":"2023","journal-title":"HLA"},{"issue":"7","key":"10.1016\/j.ajt.2025.12.286_bib164","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/TP.0000000000004012","article-title":"Shotgun immunoproteomics for identification of nonhuman leukocyte antigens associated with cellular dysfunction in heart transplant rejection","volume":"106","author":"Gates","year":"2022","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib165","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.kint.2021.09.029","article-title":"Non-HLA antibodies targeting angiotensin II Type 1 receptor and endothelin-1 Type A receptors induce endothelial injury via beta2-arrestin link to mTOR pathway","volume":"101","author":"Catar","year":"2022","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib166","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1681\/ASN.2021050689","article-title":"CRISPR\/Cas9-engineered HLA-deleted glomerular endothelial cells as a tool to predict pathogenic non-HLA antibodies in kidney transplant recipients","volume":"32","author":"Lamarth\u00e9e","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ajt.2025.12.286_bib167","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3390\/diagnostics11122366","article-title":"The summarized assessment of endothelin A receptor expression in renal transplant compartments associated with antibody-mediated rejection","volume":"11","author":"Banasik","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ajt.2025.12.286_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101474","article-title":"A descriptive analysis of non-human leukocyte antigens present in renal transplant donor-recipient pairs","volume":"69","author":"Sisk","year":"2021","journal-title":"Transpl Immunol"},{"issue":"10","key":"10.1016\/j.ajt.2025.12.286_bib169","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001215","article-title":"Increased autoantibodies against Ro\/SS-A, CENP-B, and La\/SS-B in patients with kidney allograft antibody-mediated rejection","volume":"7","author":"Clotet-Freixas","year":"2021","journal-title":"Transplant Direct"},{"key":"10.1016\/j.ajt.2025.12.286_bib170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687715","article-title":"Humanized mouse model as a novel approach in the assessment of human allogeneic responses in organ transplantation","volume":"12","author":"Ajith","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib171","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3390\/jcm10030422","article-title":"Endothelin A receptors expressed in glomeruli of renal transplant patients may be associated with antibody-mediated rejection","volume":"10","author":"Nowa\u0144ska","year":"2021","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.286_bib172","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2215\/CJN.00570122","article-title":"Association of HLA mismatches and histology suggestive of antibody-mediated injury in the absence of donor-specific anti-HLA antibodies","volume":"17","author":"Senev","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ajt.2025.12.286_bib173","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajt.2023.10.004","article-title":"Report of the 2022 Banff Heart Concurrent: focus on non-human leukocyte antigen antibodies in rejection and the pathology of \u2018mixed\u2019 rejection","volume":"24","author":"Fedrigo","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2025.12.286_bib174","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.861583","article-title":"Extracellular vesicles mediate immune responses to tissue-associated self-antigens: role in solid organ transplantations","volume":"13","author":"Ravichandran","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ajt.2025.12.286_bib175","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1097\/TP.0000000000005363","article-title":"Heterogeneity of non-HLA antibody prevalence in kidney antibody-mediated rejection with the commercial Luminex assays","volume":"109","author":"Obri\u015fc\u0103","year":"2025","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2025.12.286_bib176","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/TP.0000000000004307","article-title":"Can We Use eplets (or Molecular) Mismatch Load Analysis to Improve Organ Allocation? The hope and the hype","volume":"107","author":"Tambur","year":"2023","journal-title":"Transplantation"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525034562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525034562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:55:13Z","timestamp":1784717713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613525034562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":176,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1600613525034562"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2025.12.286","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sensitization in organ transplantation: Assessment of Risk (STAR) 2025 meeting group report","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2025.12.286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}